Skip to main content
Bioceltix S.A. logo

Bioceltix S.A. — Investor Relations & Filings

Ticker · BCX ISIN · PLBCLTX00019 LEI · 259400QZD5JYK8SLZU51 WAR Manufacturing
Open in API
Filings indexed 270 across all filing types
Latest filing 2022-07-01 Share Issue/Capital Cha…
Country PL Poland
Listing WAR BCX

About Bioceltix S.A.

https://bioceltix.com/en/

Bioceltix S.A. is a biopharmaceutical company that develops stem cell-based medicinal products for veterinary use. The company focuses on creating therapies that utilize Mesenchymal Stem Cells (MSCs) as the active pharmaceutical ingredient. Its product pipeline is aimed at treating immunological and inflammatory conditions in companion animals, including dogs, cats, and horses. A key area of development includes treatments for conditions such as atopic dermatitis in dogs and degenerative joint disease.

Recent filings

Filing Released Lang Actions
Zawarcie aneksów do umów lock-up przez akcjonariuszy Emitenta - Content (PL)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement from the Management Board ("Zarząd") of Bioceltix S.A. It details amendments (aneks) to existing lock-up agreements ("umów o ograniczeniu rozporządzania akcjami Emitenta") concerning specific shareholders and their shareholdings. This type of announcement, which concerns restrictions on the disposal of shares by key parties (shareholders/insiders), is closely related to insider transactions or significant ownership changes. However, it is not a Director's Dealing (DIRS) as it concerns major shareholders, not necessarily directors, and it is not a standard Major Shareholding Notification (MRQ) which usually reports crossing a threshold. Since it involves changes to agreements restricting the trading of a significant block of shares, it falls under the general category of regulatory disclosures related to share capital or ownership structure changes. Given the options, this specific type of agreement modification announcement is best categorized as a general Regulatory Filing (RNS) or potentially related to Capital/Financing Update (CAP) or Major Shareholding Notification (MRQ). Because it is a specific disclosure about restrictions on share disposal by major shareholders, and not a standard report, RNS is the most appropriate fallback for specific, non-standard regulatory disclosures not covered by other codes. It is a direct regulatory disclosure to the market.
2022-07-01 Polish
Uzyskanie zgody na przeprowadzenie badania na pacjentach klinicznych dla kandydata na produkt leczniczy BCX-CM-J w Portugalii - Content (PL)
Regulatory Filings Classification · 1% confidence The document text is a short announcement from the Management Board ('Zarząd') of Bioceltix S.A. regarding obtaining approval from the Portuguese regulatory body (DGAV) to conduct a planned field veterinary clinical trial for a drug candidate (BCX-CM-J). This announcement details a significant step in the development and potential commercialization of a product. It is not a full financial report (10-K, IR), an earnings release (ER), or a transcript (CT). It relates to the progress of the company's core product development, which is often categorized under general regulatory or investor updates. Given the specific nature of obtaining regulatory approval for a clinical trial, it is best classified as a general Regulatory Filing (RNS) as it is a mandatory disclosure of a material event that doesn't fit the more specific categories like M&A (TAR) or Capital Changes (CAP). The document length is very short (1064 chars), suggesting it is an announcement rather than a comprehensive report.
2022-06-29 Polish
Informacja z dnia 21 czerwca 2022 roku przekazana na podstawie art. 69 ust. 1 ustawy o ofercie publicznej i warunkach wprowadzania instrumentów finansowych do zorganizowanego systemu obrotu i spółk...
Major Shareholding Notification Classification · 1% confidence The document is a formal notification in Polish, explicitly referencing 'ART. 69 UST. 1 USTAWY O OFERCIE PUBLICZNEJ...' (Article 69, Paragraph 1 of the Public Offering Act). This structure is characteristic of mandatory disclosures in Poland regarding changes in significant shareholdings. The content details the change in the percentage of votes held by an 'Akcjonariusz' (Shareholder) in 'Bioceltix S.A.' before and after a sale of shares (from 6.147% to 3.439%). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. The closest matching category is 'Major Shareholding Notification' (MRQ).
2022-06-22 Polish
Korekta raportu bieżącego nr 21/2022 - Content (PL)
Major Shareholding Notification Classification · 1% confidence The document is a regulatory announcement from Bioceltix S.A. stating that an incorrect document was attached to a previous current report (raport bieżący nr 21/2022) and is now resubmitting the correct notification. The core content being re-submitted is a notification received from a shareholder (Leonarto VC Spółka akcyjna ASI Sp.k.) regarding a decrease in their total voting rights at the General Meeting, citing Article 69 of the Polish Public Offering Act. This type of notification regarding changes in significant share ownership or voting rights thresholds directly corresponds to the Major Shareholding Notification category. Although the document is a correction/resubmission, the underlying information being conveyed is a change in major shareholding/voting rights, making 'MRQ' (Major Shareholding Notification) the most appropriate specific classification over the general 'RNS' (Regulatory Filings). The document length is short (1054 chars) and it is announcing the content of a notification, but since the content itself is a specific regulatory filing type (change in voting rights), MRQ is preferred over RPA.
2022-06-22 Polish
Informacja z dnia 21 czerwca 2022 roku przekazana na podstawie art. 69 ust. 1 ustawy o ofercie publicznej i warunkach wprowadzania instrumentów finansowych do zorganizowanego systemu obrotu i spółk...
Capital/Financing Update Classification · 1% confidence The document text is very short (660 characters) and contains a formal declaration ('Oświadczenie Spółki') signed by the CEO and a Board Member regarding the accuracy of information contained within a 'Prospekt' (Prospectus). A Prospectus is a key document related to capital raising, offering securities, or listing. Since this is a formal declaration about the accuracy of a Prospectus, it strongly relates to financing activities or the initial offering documentation. Given the options, 'Capital/Financing Update' (CAP) is the most appropriate category as it covers fundraising and capital structure changes, which necessitate a prospectus and such declarations. It is not a full report, an earnings release, or a standard regulatory filing announcement, but a specific legal declaration tied to a financing document.
2022-06-22 Polish
Zawiadomienie o zmianie udziału w ogólnej liczbie głosów na Walnym Zgromadzeniu Emitenta - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document text is very short (639 characters) and explicitly states that a notification regarding a change in the total number of votes at the General Meeting (Walne Zgromadzenie Spółki) has been received, and the content of this notification is attached as an appendix ('Treść otrzymanego zawiadomienia stanowi załącznik do niniejszego raportu.'). This structure—announcing the receipt of a filing/notification and attaching the actual content—strongly suggests a regulatory announcement rather than the full report itself. The content concerns a change in shareholding/voting rights, which aligns with the definition of Major Shareholding Notification (MRQ) or potentially a general Regulatory Filing (RNS). Since the core subject is a change in the total number of votes/shareholding percentage reported under Polish public offering law (art. 69), MRQ is the most specific fit for changes in significant ownership thresholds, even if the document itself is the announcement wrapper.
2022-06-22 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.